Hannah Valantine - Dec 29, 2021 Form 4/A - Amendment Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Director
Signature
/s/ Hannah A. Valantine, M.D.
Stock symbol
BBIO
Transactions as of
Dec 29, 2021
Transactions value $
$24,948
Form type
4/A - Amendment
Date filed
6/30/2025, 05:49 PM
Date Of Original Report
Jan 3, 2022
Previous filing
Jun 30, 2025
Next filing
May 27, 2022
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Valantine Hannah Director C/O BRIDGEBIO PHARMA, INC., 3160 PORTER DR., SUITE 250, PALO ALTO /s/ Hannah A. Valantine, M.D. 2025-06-30 0001855608

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Purchase $24.9K +1.75K +113.62% $14.24 3.29K Dec 29, 2021 Direct
holding BBIO Common Stock 2.69K Dec 29, 2021 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.